|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Trade accounts receivable, less allowances of $184 and $33, respectively | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total trade accounts receivable, less allowances of $184 and $33, respectively | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepayments to vendors | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Receivable for claimed Employee Retention Tax Credit | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease, right-of-use asset | ||||||||||||||||||||
| Advance for investment in joint venture | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued legal and professional fees | ||||||||||||||||||||
| Accrued payroll and related benefits | ||||||||||||||||||||
| Accrued sales commissions | ||||||||||||||||||||
| Accrued warranty reserve | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Promissory notes payable, net of discounts and loan origination fees | ||||||||||||||||||||
| Total promissory notes payable, net of discounts and loan origination fees | ||||||||||||||||||||
| Related party promissory notes payable | ||||||||||||||||||||
| Credit line borrowings, net of loan origination fees | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred stock, par value $0.0001 per share: Authorized: 5,000,000 shares (3,300,000 designated as Series A Convertible Preferred Stock) at June 30, 2026 and December 31, 2025 Issued and outstanding: 876,447 at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, par value $0.0001 per share: Authorized: 50,000,000 shares at June 30, 2026 and December 31, 2025 Issued and outstanding: 6,369,222 at June 30, 2026 and 6,306,433 at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
